Stabilised GHRH Analogue

Tesamorelin Australia

Everything researchers need to know about Tesamorelin — mechanism, published dosing protocols, side effect profiles, reconstitution, and how to source third-party tested Tesamorelin in Australia.

Shop Tesamorelin — From $69.00 Dosage guide

Quick facts

Also known as: GHRH Analogue (Egrifta analogue)
Form: Lyophilised powder (>99% purity)
Variants: 2 mg, 5 mg, 10 mg
🇦🇺 3–5 business days

HPLC/MS VerifiedCOA DocumentedAU Same-Day DispatchPayID AcceptedHPLC/MS VerifiedCOA DocumentedAU Same-Day DispatchPayID AcceptedHPLC/MS VerifiedCOA DocumentedAU Same-Day DispatchPayID Accepted

Overview

What Is Tesamorelin?

Tesamorelin is a stabilised growth hormone-releasing hormone (GHRH) analogue with a trans-3-hexenoic acid modification that enhances its stability and bioavailability. It is one of the few GHRH analogues with extensive clinical research data, particularly regarding visceral adipose tissue reduction.

Also known as GHRH Analogue (Egrifta analogue), Tesamorelin is supplied as a lyophilised research peptide for laboratory use only. Clinical research demonstrates Tesamorelin selectively stimulates pituitary GH secretion, resulting in physiological GH pulsatility. Studies show significant reductions in visceral adipose tissue (VAT) with preserved subcutaneous fat, and improvements in lipid profiles. It maintains the hypothalamic-pituitary feedback loop unlike exogenous GH.

View Tesamorelin Products

Mechanism

How Tesamorelin Works — Research Mechanism

Clinical research demonstrates Tesamorelin selectively stimulates pituitary GH secretion, resulting in physiological GH pulsatility. Studies show significant reductions in visceral adipose tissue (VAT) with preserved subcutaneous fat, and improvements in lipid profiles. It maintains the hypothalamic-pituitary feedback loop unlike exogenous GH.

Stabilised GHRH analogue with trans-3-hexenoic acid modification
Selective pituitary GH stimulation preserving feedback loops
Significant visceral adipose tissue reduction in clinical research
Physiological GH pulsatility maintained unlike exogenous GH
Extensive clinical research data on lipid profile effects

Research reference

Tesamorelin Dosage — Published Research Protocols

The following reference points are drawn from published research literature. These figures are provided for research reference only and do not constitute dosing recommendations. Tesamorelin is sold strictly for laboratory research use.

Protocol tier	Published research detail
Research reference	Published literature varies by model and endpoint — consult primary sources for protocol-specific dosing in laboratory settings
Administration route	Subcutaneous injection is most common in published peptide research protocols
Frequency	Dosing frequency depends on compound half-life and research design — daily to weekly intervals reported in literature
Available vial sizes	2 mg, 5 mg, 10 mg — select based on your laboratory protocol requirements
Titration	Many research protocols start at lower doses and escalate to assess receptor response and tolerability in models

Research use only: FOR LABORATORY RESEARCH USE ONLY. Not for human consumption, injection, or therapeutic use. All products are sold strictly as research chemicals. By purchasing, you confirm you are 18+ and agree to use products solely for legitimate research purposes.

Order Research-Grade Tesamorelin — From $69.00

Safety research

Tesamorelin Side Effects — Research Findings

Side effect profiles documented in published Tesamorelin research depend on dose, route of administration, and model system. The following are commonly reported findings from research literature — not from personal use contexts.

Injection site reactions common to peptide administration routes
Transient water retention reported in some GH-axis research models
Headache and mild fatigue documented in GHRH/GHRP combination studies
Effects generally resolve with dose adjustment in published protocols

Handling

Reconstituting Tesamorelin

Tesamorelin is supplied as a lyophilised powder and must be reconstituted before use in laboratory protocols. Use bacteriostatic water (0.9% benzyl alcohol) for multi-dose vials. Inject diluent slowly down the inside wall of the vial — do not shake vigorously.

Bacteriostatic water is available from EvoPeak. Store reconstituted peptide at 2–8°C and lyophilised powder at −20°C.

Shop bacteriostatic water

Australia

How to Get Tesamorelin in Australia

Researchers in Australia can source Tesamorelin through EvoPeak — a local supplier offering third-party tested research compounds with batch-specific COA documentation and domestic shipping.

1
Browse Tesamorelin variants (2 mg, 5 mg, 10 mg) on the EvoPeak product page
2
Review the certificate of analysis (COA) for HPLC purity and mass spectrometry identity verification
3
Select your vial size and add to cart — prices include GST with same-day Australian dispatch
4
Receive your order with batch-specific quality documentation for laboratory traceability

Buy Tesamorelin — Shipped from Australia — From $69.00

Quality Standard

Research compounds need evidence, not guesswork.

Every shopping path leads back to the same core standard: research-use positioning, third-party quality signals, transparent documentation, and careful handling guidance.

HPLC/MS verified

Purity and identity checks support confident compound selection for controlled research.

Endotoxin screened

Quality review extends beyond purity so researchers can evaluate handling risk.

Batch documentation

COA-first product pages keep quality signals close to every purchase decision.

Australia shipped

Local fulfilment keeps delivery predictable for Australian research customers.

FAQ

Tesamorelin — Common Questions

What is Tesamorelin?

Stabilised GHRH analogue for visceral adiposity and GH research. Tesamorelin is a stabilised growth hormone-releasing hormone (GHRH) analogue with a trans-3-hexenoic acid modification that enhances its stability and bioavailability. It is one of the few GHRH analog… It is supplied for laboratory research use only.

What is the Tesamorelin dosage used in research?

Published research uses varying doses depending on the model and endpoint. EvoPeak supplies 2 mg and 5 mg and 10 mg vials. All dosage information is for research reference only and does not constitute recommendations.

What are the side effects of Tesamorelin?

Side effect profiles in published research depend on dose, route, and model system. Consult primary literature for compound-specific findings. All information is drawn from research contexts, not personal use.

Can I buy Tesamorelin in Australia?

Yes. EvoPeak supplies research-grade Tesamorelin to Australian researchers with HPLC/MS verification, batch-specific COA documentation, and domestic shipping. Products are for laboratory research use only.

How do I get Tesamorelin in Australia?

Order from the EvoPeak shop page, select your vial size, review the COA, and checkout with local Australian fulfilment.

How do I reconstitute Tesamorelin?

Tesamorelin is supplied as lyophilised powder. Reconstitute with bacteriostatic water, inject diluent slowly down the vial wall without shaking, and store at 2–8°C once reconstituted. Bacteriostatic water is available from EvoPeak.

What purity standard does EvoPeak Tesamorelin meet?

Every batch undergoes HPLC purity analysis (targeting >99%), mass spectrometry identity verification, and endotoxin screening. Batch-specific COAs are available on the product page.